Pelemans, H., Esnouf, R., Dunkler, A., Parniak, M., Vandamme, A., Karlsson, A., . . . Balzarini, J. (1997). Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1.

Pelemans, H., R. Esnouf, A. Dunkler, M. Parniak, A. Vandamme, A. Karlsson, E. De Clercq, J. Kleim, and J. Balzarini. Characteristics of the Pro225His Mutation in Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase That Appears Under Selective Pressure of Dose-escalating Quinoxaline Treatment of HIV-1. 1997.

Pelemans, H., et al. Characteristics of the Pro225His Mutation in Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase That Appears Under Selective Pressure of Dose-escalating Quinoxaline Treatment of HIV-1. 1997.